Warning: Attempt to read property "ID" on null in /home/asgard01/technology-asgard.com/www/wp-content/plugins/lets-review/frontend/class-lets-review-frontend.php on line 1235
{"version":"1.0","provider_name":"Asgard Technology","provider_url":"https:\/\/www.technology-asgard.com\/en\/","author_name":"Asgard Technology","author_url":"https:\/\/www.technology-asgard.com\/en\/author\/asgard_0727\/","title":"SAT (Silver-Amide-THC) - Asgard Technology","type":"rich","width":600,"height":338,"html":"

SAT (Silver-Amide-THC)<\/a><\/blockquote><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","description":"UDC: 547.551.525.211.1:546.57:615.212.7:542.91 SYNTHESIS AND PROSPECTS OF PHARMACOLOGICAL ACTIVITY OF HYBRID MOLECULES BASED ON SULFANILAMIDE MODIFIED WITH A SILVER ATOM AND TETRAHYDROCANNABINOL: THEORETICAL JUSTIFICATION AND SYNTHETIC APPROACHES Author: Sukhachov Den\u0443s Pavlovych AbstractIntroduction. Modern medicinal chemistry is actively developing the direction of “polypharmacology,” creating hybrid molecules capable of simultaneously affecting several pathological targets. Sulfanilamides are classical antibacterial agents whose mechanism of action involves competitive antagonism with para-aminobenzoic acid (PABA). Meanwhile, cannabinoids, particularly \u0394\u2079-tetrahydrocannabinol (THC), demonstrate a wide range of pharmacological activities, including […]"}